Increasing Prevalence of Allergies to boost demand for the Auto-Injectors Market

Auto-injectors are anticipated to offer vast opportunities to investors owing to high demand in biologics development. These are specialized instruments that can be used to reduce needle phobia and to avoid needle stick injury. Increasing adoption of auto-injectors to advantages such as accuracy, increased safety and minimal discomfort is likely drive auto-injectors market towards rapid growth. Reduction in dependence on medical experts is boosting the application of auto-injector and is expected to increase the revenue growth of the market. 

According to Transparency Market Research the market for auto-injectors will gain more traction, due to its economic healthcare costs and reduced time at in-patient and out-patient units. It is expected that its performance will be better owing to rise in geriatric population and rise in number of patients for anaphylaxis treatment.

Obtain Report Details @

What are the factors fueling the growth of the global auto-injectors market?

Rising self-medication practices and growing demand for targeted drug delivery systems, coupled with government initiative fueling the demand for auto-injectors in the global market. Furthermore, new drug delivery systems and new formulations along with developments and applications are expected to drive the market for auto-injectors. Additionally, increased level of the usage of devices in case of severe diseases and increase in the incidents of diseases are propelling the market growth.

Furthermore, rising healthcare expenditure give rise to research and development capitalizing, various additional factors such as increasing cases of sclerosis and high production of biologics are also boosting the growth of the auto-injectors market.

Which is the Most Rapidly Growing Region in the global auto-injectors market?

Based on the geographical structure, the market for auto-injector has been segmented into Europe, North America, Latin America, the Middle East and Africa, and Asia Pacific. Among all these regions, North America has been dominating this market owing to economic stability to purchase expensive auto-injectors, favorable government’s initiatives and policies.  Moreover, Asia Pacific region is anticipated to emerge as a major market for auto-injectors in the coming years on account of rising prevalence of anaphylaxis coupled with rising awareness about severe treatment methods accessible in the market.

Developing countries from Asia Pacific region such as China and India are focusing on the research and development activities which is expected to boost the auto-injectors market in these countries.

Which are the leading participants of the global auto-injectors market?

The auto-injectors market is dominated by a few domestic as wells as international players. Mylan, Inc., Sanofi, SHL Group, Becton, Biogen Idec, Inc., Antares Pharma, Ypsomed Holdings AG, Unilife Corporation, Dickinson and Compnay, Pfizer, Inc., and Novartis International AG. The auto-injector market is primarily innovation driven, thus market players are continuously active in research and development activities to come up with technological and product level advancements.

Kaleo, pharmaceutical company have raised the price of an overdose antidote from February 2017 and planning to come with an alternative to the EpiPen which will be more than seven times cost as compared to the leading drug. This decision may incurred heavy competition in the auto-injectors market in the near future.

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports